{{Rsnum
|rsid=3212891
|Gene=CCND1
|Chromosome=11
|position=69650739
|Orientation=plus
|GMAF=0.3792
|Gene_s=CCND1,LOC100996515
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 37.2 | 44.2 | 18.6
| HCB | 73.7 | 24.1 | 2.2
| JPT | 75.2 | 23.9 | 0.9
| YRI | 24.0 | 54.1 | 21.9
| ASW | 22.8 | 43.9 | 33.3
| CHB | 73.7 | 24.1 | 2.2
| CHD | 77.1 | 22.9 | 0.0
| GIH | 36.6 | 46.5 | 16.8
| LWK | 34.5 | 40.0 | 25.5
| MEX | 22.4 | 44.8 | 32.8
| MKK | 16.0 | 56.4 | 27.6
| TSI | 33.3 | 50.0 | 16.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=19258477
|Title=Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=18174243
|Title=Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
|OA=1
}}

{{PMID Auto
|PMID=19124506
|Title=Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.
|OA=1
}}

{{PMID Auto
|PMID=19543528
|Title=Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}